Related Experiment Video
Updated: Apr 27, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Aspartame and Risk of Cancer: A Meta-analytic Review
Sreekanth Mallikarjun1, Rebecca McNeill Sieburth
1a Department of Technology and Society, Stony Brook University , Stony Brook , New York , USA.
Abstract:
Aspartame (APM) is the most commonly used artificial sweetener and flavor enhancer in the world. There is a rise in concern that APM is carcinogenic due to a variation in the findings of the previous APM carcinogenic bioassays. This article conducts a meta-analytic review of all previous APM carcinogenic bioassays on rodents that were conducted before 31 December 2012. The search yielded 10 original APM carcinogenic bioassays on rodents. The aggregate effect sizes suggest that APM consumption has no significant carcinogenic effect in rodents.
Insights
Aspartame (APM), a common artificial sweetener, has raised cancer concerns. A meta-analysis of rodent studies indicates no significant carcinogenic effect from APM consumption.
Area of Science:
- Toxicology
- Food Science
- Oncology
Background:
- Aspartame (APM) is a widely used artificial sweetener and flavor enhancer.
- Recent concerns regarding APM's potential carcinogenicity have emerged due to conflicting study findings.
Purpose of the Study:
- To conduct a meta-analytic review of rodent bioassays on APM carcinogenicity.
- To aggregate findings from studies published before December 31, 2012.
Main Methods:
- Systematic literature search for APM carcinogenic bioassays on rodents.
- Meta-analysis of 10 identified original studies.
- Aggregate effect size calculation to determine overall carcinogenic potential.
Main Results:
- The meta-analysis included 10 rodent bioassays on aspartame.
- Aggregate effect sizes showed no statistically significant carcinogenic effect of APM.
- Findings suggest APM consumption is not linked to cancer in rodents.
Conclusions:
- Based on available rodent studies, aspartame consumption does not pose a significant carcinogenic risk.
- The meta-analysis provides a consolidated view of early evidence on APM safety.
- Further research may be warranted to address ongoing public health concerns.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Mutagenicity and Carcinogenicity
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Psychoneuroimmunology: Diabetes and Cancer

